The Global Autism Gap: Most Autistic People Live Where Support Is Scarce

Most of the world’s autistic people live in low- and middle-income countries. Most of the specialists, diagnostic services and research do not. Where careful studies have looked, autism is not rare in poorer countries — what is rare is anyone trained and funded to recognise it, and support once they do.

The gap is easy to picture. It is the parent in a rural district who learns that the only clinic able to give a diagnosis is in the capital, a long and costly journey away. It is the autistic child in an ordinary classroom whom no one has ever assessed. It is also something the statistics rarely show: the parents who founded schools when none would take their children, the community health workers learning to coach families, and the researchers in Addis Ababa, Kilifi, Goa and Rawalpindi building the evidence their own countries need. This is a story about where the world has chosen to put its resources, not about what poorer countries lack.

Four in five autistic people live outside the most developed countries

The GBD 2021 study estimated that 61.8 million people worldwide were autistic in 2021^[2]. Broken down by the study’s Socio-demographic Index (SDI), a measure of development, about 11.1 million of them lived in the highest-SDI group of countries. The rest — about 50.8 million people, roughly four in five — lived in the high-middle, middle, low-middle and low-SDI groups, with the largest single share (17.1 million) in the middle group^[1].

That distribution follows population, not rarity: the same model puts age-standardised autism prevalence at 1,090 per 100,000 people in the high-income super-region, 890 in sub-Saharan Africa and 686 in south Asia — differences, but nothing that makes autism a rich-country condition^[2]. For young children, an earlier GBD analysis estimated 52.9 million under-fives with a developmental disability in 2016 (autism alongside epilepsy, intellectual disability, hearing and vision loss and ADHD), about 95% of whom lived in low- and middle-income countries^[5]. The team behind a trial in India and Pakistan put the number of autistic children in south Asia alone at more than 5 million^[6].

As Petrus de Vries, a child psychiatrist at the University of Cape Town, put it in 2016: “Most people with autism spectrum disorders (ASDs) live in low and middle-income countries, yet almost everything we know about ASD comes from high-income countries”^[7].

Where autism is counted, it is found — but most places have not been counted

Those global numbers carry an important caveat. The World Health Organization says plainly that “the prevalence of autism in many low- and middle-income countries is unknown”^[8]. The GBD model drew on local prevalence data from only about three dozen of the 204 countries it covers; for the rest, it fills the gaps by drawing on estimates from surrounding locations^[2].

A 2022 systematic review of the autism prevalence estimates published from 2012 to 2021 shows how lopsided the counting is. Of 99 estimates from 34 countries, 31 came from WHO’s European Region and 30 from the Americas. The South-East Asia Region, which includes India and Bangladesh, produced eight. The African Region produced two^[9].

Where researchers have looked properly, they find autistic people in numbers that echo richer countries. A 2026 review by researchers in Brazil, Angola and Mozambique of seven studies from Egypt, Kenya, Uganda and Nigeria, covering 71,341 people, found a pooled prevalence of clinically confirmed autism of about 1% and concluded that estimates in Africa “appear comparable to those reported in high-income countries”^[10]. A nationwide multi-centre study of 6–12-year-olds in China, led from the Children’s Hospital of Fudan University in Shanghai, confirmed 363 autistic children — and 43.3% of them were diagnosed for the first time by the study itself, most of them (90.4%) attending ordinary schools^[11]. That is the detection gap in one figure. Our companion piece on how many people are autistic worldwide looks at why prevalence estimates vary so much between countries.

Specialists are scarcest where most autistic children live

Recognition needs people. WHO’s Mental Health Atlas 2024, covering 144 countries, shows how unevenly they are spread. The median number of specialised child and adolescent mental health workers — psychiatrists, nurses, psychologists, social workers and others — was 0.05 per 100,000 people in low-income countries and 0.12 in lower-middle-income countries, against 2.14 in upper-middle-income and 4.56 in high-income countries^[3]. The high-income median is about 90 times the low-income one.

For child and adolescent psychiatrists specifically, the median in low-income countries rounds to zero (0.00 per 100,000), and in lower-middle-income countries it is 0.03, compared with 1.26 in high-income countries. In the adult mental health workforce, low-income countries have a median of just 0.1 psychiatrists per 100,000 people — “one per million people” — against 7 per 100,000 in high-income countries^[3]. These are not autism specialists, but they are the clearest global measure of specialist capacity for children.

Behind the medians are real service maps. At the time of a 2016 study by researchers at Addis Ababa University and in the UK, Ethiopia, with more than 96 million people, had 60 practising psychiatrists, two of them child psychiatrists, and a formal autism diagnosis could be obtained only at specialised clinics in Addis Ababa^[12]. Families filled the gap themselves. The Joy Center was founded in 2002 by a mother whose autistic child had been turned away by many regular schools; it hosted 80 children with more than 500 on its waiting list, while the Nehemiah Autism Center enrolled 40 with 250 waiting^[12].

Tools are a barrier too: an international group of researchers pointed in 2015 to “the high cost of proprietary tools for diagnosing autism and for delivering evidence-based therapies” and the cost of training people to use them^[13]. Culturally appropriate screening and diagnostic instruments are, in the words of a 2020 review, “lacking in most low- and middle-income settings where the majority of the global autism population lives”^[14]. How long families wait between first concern and diagnosis around the world is covered in our piece on age at autism diagnosis.

Research follows funding, not people

A 2017 review led from Duke University and the University of Cape Town counted PubMed-indexed autism publications by continent up to October 2015. Of 24,467 publications identified, 120 came from sub-Saharan Africa, compared with 7,577 from Europe and 11,560 from North America (a paper could count towards more than one region)^[4]. Searching everything ever published on autism in sub-Saharan Africa, the same team found 53 publications — and “no epidemiological, early intervention, school-based or adult studies”^[4].

The pattern is not confined to Africa. “Most research into the epidemiology, etiology, clinical manifestations, diagnosis and treatment of autism is based on studies in high income countries,” the 2015 group wrote^[13]; fewer than 20% of the world’s population lives in those countries, “but autism studies are almost exclusively based on this selected population”^[14].

This matters beyond fairness: tools and programmes built in a narrow slice of the world may not fit the languages, families and school systems where most autistic people live. As de Vries concluded, “research priorities have to be determined by local needs”^[7].

Stigma widens the gap — and families and communities are pushing back

Stigma is not a problem peculiar to poorer countries. WHO notes that autistic people “are often subject to stigma and discrimination, including unjust deprivation of health care, education and opportunities”^[8]. But where services and information are scarce, it has more room to grow. The 2014 World Health Assembly resolution on autism was “deeply concerned” that autistic people and their families “face major challenges including social stigma, isolation and discrimination, and that children and families in need, especially in low resource contexts, often have poor access to appropriate support and services”^[15].

In a survey by Addis Ababa University and King’s College London researchers of 102 caregivers of children with developmental conditions at two child mental health clinics in Addis Ababa (a third of the children were autistic), 43.1% worried about being treated differently, 45.1% said they felt ashamed about their child’s condition and 26.7% tried to keep it secret^[16]. The authors called for interventions that raise awareness, reduce stigma and strengthen caregivers’ support. Our piece on parents’ and carers’ health looks at what that support means across countries.

Some of the strongest pushes for change have come from low- and middle-income countries themselves, including parent-founded organisations such as Action for Autism in India^[17]. In 2011 a conference in Dhaka, organised with the Government of Bangladesh, WHO and partners, produced the Dhaka Declaration on autism and developmental disorders; WHO’s South-East Asia regional committee passed its own resolution in 2012^[17], which the global resolution explicitly recalls^[15].

Task-sharing can work: families and community health workers can close part of the gap

If there will not be enough specialists for decades, the question is what trained non-specialists can do. The evidence, much of it produced in low- and middle-income countries, is encouraging but young.

• India and Pakistan (PASS). A trial by researchers including Atif Rahman, Gauri Divan of Sangath in Goa and Syed Usman Hamdani of the Human Development Research Foundation in Pakistan adapted a UK parent-mediated communication programme for delivery by non-specialist health workers in Goa and Rawalpindi. Of 65 children aged 2–9, 32 were allocated to the programme and 26 of them (81%) completed it. It improved parents’ synchronous responses to their child (effect size 1.61) and children’s initiation of communication with their parent (0.99), although time in mutual shared attention fell (−0.70)^[6].
• Rural India (PASS Plus). A 40-family pilot added support for co-occurring needs; 89% of families partially or fully completed it. Effects on parent–child communication were large, the change in the trial’s autism symptom score was small with a confidence interval including zero, and parents’ mental health improved^[18].
• New Delhi (COMPASS). A scale-up trial designed to recruit 240 children aged 2–9 through two government hospitals, with Accredited Social Health Activists among those delivering the programme^[19]. Sangath, which lists COMPASS among its projects, describes it as the largest randomised trial for autism in a low- or middle-income country; it ran from 2018 to 2024, and peer-reviewed results are awaited^[20].
• WHO Caregiver Skills Training (CST). A programme for families of children with developmental delays or disabilities, including autism, designed to be delivered by non-specialists in low-resource settings, with nine core group sessions and three home visits, and field-tested in more than 30 countries by 2019^[21]. In Kenya, a team led by Amina Abubakar at the KEMRI-Wellcome Trust Research Programme in Kilifi and the Aga Khan University translated it into Swahili and piloted it with 90 caregivers of children with developmental disabilities in rural Kilifi and Nairobi’s Korogocho informal settlement; 86% of those assigned to the programme attended at least two-thirds of sessions, and caregivers described better awareness of support and help managing stigma^[22]. A cluster randomised trial across four sites in Kenya and Ethiopia (SPARK) aims to recruit 544 caregiver–child pairs^[23].

Across the wider literature, a 2019 systematic review of 33 randomised trials of non-specialist-delivered autism programmes pooled results showing improvements in outcomes including communication (standardised mean difference 0.23), parental distress (0.33) and the parent–child relationship (0.67)^[24]. Many trials are small and effects vary by outcome: this is population-level evidence that task-sharing can help services, not proof that any one programme suits every family, and not advice about any individual child.

What the evidence asks of us

Governments have already agreed what should happen. In 2014 the World Health Assembly urged every member state, among other things^[15]:

• “to mainstream into primary health care services the promotion and monitoring of child and adolescent development in order to ensure timely detection” of autism and other developmental conditions;
• “to increase the capacity of health and social care systems” and to shift care “towards community-based, non-residential services”;
• “to support research and public awareness-raising and stigma-removal campaigns”;
• “to identify and address disparities in access to services”, “to improve health information and surveillance systems” and “to promote context-specific research”.

More than a decade on, the workforce figures above^[3] show how far there is to go. The evidence points to five priorities:

• Count autistic people where they live. The GBD authors “urge researchers to initiate more inclusive population representative diagnostic surveys with active case finding to enhance geographical coverage”^[2]. Services are planned from data.
• Build diagnostic capacity close to home. The African prevalence review calls for urgent action to “expand diagnostic confirmation services and strengthen training for primary healthcare professionals”^[10].
• Fund task-sharing at scale, and evaluate it honestly. Trials such as COMPASS and SPARK will show what works in routine services^[20][23].
• Make the tools free. Open-source and open-access tools and training would remove a cost barrier that falls hardest on the poorest services^[13].
• Fund research led from, and set by, low- and middle-income countries. The publication imbalance^[4] will not close through goodwill alone; funders can put money and decisions in the hands of local researchers and autistic-led and family-led organisations.

For autism organisations in wealthy countries, this is an invitation to solidarity. The research library at Autism & Health collects the evidence on other parts of that picture.

Language: this piece uses identity-first language (“autistic people”), the preference of most autistic-led organisations, and uses clinical terms such as “autism spectrum disorder” only when naming a study, quotation or diagnostic category. “Low- and middle-income countries” follows World Bank income groups; where a source uses a different grouping (such as GBD’s Socio-demographic Index or WHO regions), we say so.

Why we're publishing this

Health Insurance UK is a commercial health-insurance resource, not a charity and not a campaign. We compiled this evidence because the autistic people, families, researchers and organisations working to close the global gap — many in countries with the fewest resources — deserve the numbers clean, sourced and in one place, ready for a health ministry, a funder or a journalist. The case is theirs. Our part is to say plainly what the figures show: autistic people live everywhere, and the support they need is still concentrated in a few wealthy countries.

How to read this data

The global and regional counts of autistic people are modelled estimates from the GBD 2021 study; for most low- and middle-income countries there are no local prevalence data, so estimates are filled in from neighbouring locations. The SDI groups used in the first chart are not the same as World Bank income groups. The “four in five” figure and the “about 90 times” comparison are our own arithmetic from the published tables (the latter compares two medians). Workforce figures are medians per 100,000 total population, from countries that reported to WHO, and count mental health staff rather than autism specialists; the Atlas uses “LMIC” to mean lower-middle-income countries, its low-income median for child and adolescent mental health workers rests on 15 reporting countries, and the 0.1 and 7 psychiatrists per 100,000 figures describe the adult mental health workforce. The 95% figure for young children covers all developmental disabilities, not autism alone. Publication counts by continent can overlap. Ethiopian service figures date from 2016 and will have changed. Trial results come from specific places and are not directly comparable. This is analysis of published data, not new research.

Use this data

Free to cite with attribution to Health Insurance UK. Charities, campaigners and journalists are welcome to reuse these figures and charts. For the underlying figures as a spreadsheet, get in touch.

Important: This article summarises published research for general information. It is not medical advice and cannot be used to diagnose, treat or predict anything about an individual. If you have concerns about your own or someone else’s health, please speak to a qualified health professional.

Sources

1. Li D, Liang Z, Miao C, Li L, Li C. Age-period-cohort analysis of autism spectrum disorders-related prevalence and DALYs: based on the Global Burden of Disease Study 2021. Frontiers in Psychiatry, 2025. europepmc.org/article/MED/40352378
2. GBD 2021 Autism Spectrum Collaborators (Santomauro DF, et al.). The global epidemiology and health burden of the autism spectrum: findings from the Global Burden of Disease Study 2021. Lancet Psychiatry, 2025. europepmc.org/article/MED/39709974
3. World Health Organization. Mental Health Atlas 2024. WHO, 2025. who.int/publications/i/item/9789240114487
4. Franz L, Chambers N, von Isenburg M, de Vries PJ. Autism spectrum disorder in sub-Saharan Africa: a comprehensive scoping review. Autism Research, 2017. pmc.ncbi.nlm.nih.gov/articles/PMC5512111
5. Global Research on Developmental Disabilities Collaborators. Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Global Health, 2018. europepmc.org/article/MED/30172774
6. Rahman A, Divan G, Hamdani SU, et al. Effectiveness of the parent-mediated intervention for children with autism spectrum disorder in south Asia in India and Pakistan (PASS): a randomised controlled trial. Lancet Psychiatry, 2016. europepmc.org/article/MED/26704571
7. de Vries PJ. Thinking globally to meet local needs: autism spectrum disorders in Africa and other low-resource environments. Current Opinion in Neurology, 2016. europepmc.org/article/MED/26886354
8. World Health Organization. Autism (fact sheet), updated 17 September 2025. WHO, 2025. who.int/news-room/fact-sheets/detail/autism-spectrum-disorders
9. Zeidan J, Fombonne E, Scorah J, et al. Global prevalence of autism: a systematic review update. Autism Research, 2022. europepmc.org/article/PMC/PMC9310578
10. Ferreira IL, Mazalo JV, Prates-Baldez D, Kapczinski F, Quarantini LC. Prevalence of autism in African countries: a systematic review and meta-analysis. Trends in Psychiatry and Psychotherapy, 2026. europepmc.org/article/MED/41637193
11. Zhou H, Xu X, Yan W, et al. Prevalence of autism spectrum disorder in China: a nationwide multi-center population-based study among children aged 6 to 12 years. Neuroscience Bulletin, 2020. europepmc.org/article/MED/32607739
12. Tekola B, Baheretibeb Y, Roth I, et al. Challenges and opportunities to improve autism services in low-income countries: lessons from a situational analysis in Ethiopia. Global Mental Health, 2016. europepmc.org/article/PMC/PMC5454792
13. Durkin MS, Elsabbagh M, Barbaro J, et al. Autism screening and diagnosis in low resource settings: challenges and opportunities to enhance research and services worldwide. Autism Research, 2015. europepmc.org/article/MED/26437907
14. de Leeuw A, Happé F, Hoekstra RA. A conceptual framework for understanding the cultural and contextual factors on autism across the globe. Autism Research, 2020. pmc.ncbi.nlm.nih.gov/articles/PMC7614360
15. World Health Assembly. Resolution WHA67.8: Comprehensive and coordinated efforts for the management of autism spectrum disorders. WHO, 24 May 2014. apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R8-en.pdf
16. Tilahun D, Hanlon C, Fekadu A, et al. Stigma, explanatory models and unmet needs of caregivers of children with developmental disorders in a low-income African country: a cross-sectional facility-based survey. BMC Health Services Research, 2016. europepmc.org/article/MED/27117326
17. WHO Regional Office for South-East Asia. From awareness to action: how global health is embracing the growing challenge of autism. WHO, 4 April 2025. who.int/southeastasia/news/feature-stories/detail/from-awareness-to-action…
18. Divan G, Vajaratkar V, Cardozo P, et al. The feasibility and effectiveness of PASS Plus, a lay health worker delivered comprehensive intervention for autism spectrum disorders: pilot RCT in a rural low and middle income country setting. Autism Research, 2019. europepmc.org/article/MED/30095230
19. Roy R, Leadbitter K, Shields G, et al. A randomised controlled trial of clinical and cost-effectiveness of the PASS Plus intervention for young children with autism spectrum disorder in New Delhi, India: study protocol for the COMPASS trial. Trials, 2023. europepmc.org/article/MED/37828540
20. Sangath. COMPASS project page. Sangath, accessed September 2026. sangath.in/projects/compass
21. Salomone E, Pacione L, Shire S, et al. Development of the WHO Caregiver Skills Training Program for developmental disorders or delays. Frontiers in Psychiatry, 2019. europepmc.org/article/MED/31780960
22. Abubakar A, Mwangome E, Mwangi P, et al. Acceptability, feasibility and preliminary evaluation of the WHO caregiver skills training for children with developmental disabilities in rural and urban Kenya. BMJ Paediatrics Open, 2025. europepmc.org/article/PMC/PMC12645608
23. Washington-Nortey M, Angwenyi V, Demissie M, et al. Supporting African communities to increase resilience and mental health of kids with developmental disabilities and their caregivers using the WHO Caregiver Skills Training Programme (SPARK trial): study protocol for a cluster randomised controlled trial. Trials, 2024. europepmc.org/article/MED/39449002
24. Naveed S, Waqas A, Amray AN, et al. Implementation and effectiveness of non-specialist mediated interventions for children with autism spectrum disorder: a systematic review and meta-analysis. PLoS One, 2019. europepmc.org/article/MED/31703073